Koers Fresenius SE & Co. KGaA Other OTC
Aandelen
FSNUY
US35804M1053
Gezondheidszorgvoorzieningen & -diensten
Omzet 2024 * | 22,96 mld. 24,46 mld. | Omzet 2025 * | 24,06 mld. 25,64 mld. | Marktkapitalisatie | 15,75 mld. 16,79 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,45 mld. 1,55 mld. | Nettowinst (verlies) 2025 * | 1,78 mld. 1,9 mld. | EV/omzet 2024 * | 1,31 x |
Nettoschuld 2024 * | 14,27 mld. 15,21 mld. | Nettoschuld 2025 * | 13,48 mld. 14,36 mld. | EV/omzet 2025 * | 1,22 x |
K/w-verhouding 2024 * |
10,7
x | K/w-verhouding 2025 * |
8,78
x | Werknemers | - |
Dividendrendement 2024 * |
3,34% | Dividendrendement 2025 * |
3,79% | Vrij verhandelbaar | 73,04% |
Recentste transcriptie over Fresenius SE & Co. KGaA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 12-04-21 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 01-01-19 |
Michael Moser
CMP | Compliance Officer | - | 18-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 20-05-15 |
Wolfgang Kirsch
CHM | Chairman | 69 | 01-01-20 |
Konrad Kölbl
BRD | Director/Board Member | 64 | 16-07-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,25% | 85,35 mld. | |
+14,46% | 81,95 mld. | |
+9,37% | 28,99 mld. | |
-11,40% | 16,98 mld. | |
+0,22% | 15,35 mld. | |
+4,32% | 12,42 mld. | |
-2,34% | 11,88 mld. | |
+32,69% | 12,19 mld. | |
-31,05% | 11,89 mld. |